Literature DB >> 12942551

Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.

Galina Soboleva1, Birgit Geis, Heinrich Schrewe, Bernhard H F Weber.   

Abstract

The tissue inhibitor of metalloproteinases-3 (TIMP3) is a multifunctional protein tightly associated with the extracellular matrix (ECM). A specific type of mutation in TIMP3 which results in potentially unpaired cysteine residues at the C-terminus of the protein has been shown to cause Sorsby fundus dystrophy (SFD), an autosomal dominant retinopathy of late onset. An early finding in SFD is a striking accumulation of protein and lipid material in Bruch's membrane, a multilayered ECM structure located between the choroid and the RPE. To study the molecular mechanisms underlying SFD pathology, we recently generated two mouse lines, one deficient in Timp3 (Timp3(-/-)) and one carrying an SFD-related mutation in the orthologous murine Timp3 gene (Timp3(S156C/S156C)). We now established immortalized fibroblast cells from the mutant mouse strains and provide evidence that the various cell lines display distinct morphological and physiological features that are dependent on the mutational status of the Timp3 protein in the secreted ECM. We show that matrix metalloproteinase (MMP) activity and inhibitory properties of Timp3 are not affected by the SFD-associated mutation. We further demonstrate that Timp3(S156C) protein accumulates in the ECM of the mutant fibroblast cells and that this accumulation is not due to a prolonged turnover rate of mutant vs. normal Timp3. We also show that the relative abundance of mutant and normal Timp3 in the ECM has no measurable effects on cellular phenotypes. Together, these findings suggest (i) a functional role of normal Timp3 in pathways determining cellular morphology and (ii) a loss of this particular function as a consequence of the Ser156Cys mutation. We therefore hypothesize that SFD pathogenesis is due to a loss-of-function mutation in TIMP3. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12942551     DOI: 10.1002/jcp.10361

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

Review 2.  Sorsby fundus dystrophy: Insights from the past and looking to the future.

Authors:  Bela Anand-Apte; Jennifer R Chao; Ruchira Singh; Heidi Stöhr
Journal:  J Neurosci Res       Date:  2018-08-21       Impact factor: 4.164

3.  S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis.

Authors:  Jian Hua Qi; Ganying Dai; Philip Luthert; Shyam Chaurasia; Joe Hollyfield; Bernhard H F Weber; Heidi Stöhr; Bela Anand-Apte
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

4.  A new autosomal dominant eye and lung syndrome linked to mutations in TIMP3 gene.

Authors:  Isabelle Meunier; Béatrice Bocquet; Gilles Labesse; Christina Zeitz; Sabine Defoort-Dhellemmes; Annie Lacroux; Martine Mauget-Faysse; Isabelle Drumare; Anne-Sophie Gamez; Cyril Mathieu; Virginie Marquette; Lola Sagot; Claire-Marie Dhaenens; Carl Arndt; Patrick Carroll; Martine Remy-Jardin; Salomon Yves Cohen; José-Alain Sahel; Bernard Puech; Isabelle Audo; Sarah Mrejen; Christian P Hamel
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

5.  Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy.

Authors:  Z Saihan; Z Li; J Rice; N A Rana; S Ramsden; P G Schlottmann; S A Jenkins; C Blyth; G C Black; N McKie; A R Webster
Journal:  Mol Vis       Date:  2009-06-15       Impact factor: 2.367

6.  The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond.

Authors:  Sarah Naessens; Julie De Zaeytijd; Delfien Syx; Roosmarijn E Vandenbroucke; Frédéric Smeets; Caroline Van Cauwenbergh; Bart P Leroy; Frank Peelman; Frauke Coppieters
Journal:  Hum Mutat       Date:  2019-02-06       Impact factor: 4.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.